Understanding Sensitivity and Resistance to Pan-RAS(ON) Inhibition Across KRAS-Mutant Tumors
Champions Oncology blog
Trends in Oncology
Join our Trends in Oncology Blog to learn more about upcoming industry topics, educational information about Champions' products, and more!
Understanding Sensitivity and Resistance to Pan-RAS(ON) Inhibition Across KRAS-Mutant Tumors
Clinically Relevant 3D Tumor Models for HER2-Targeted ADC Development
Evaluating a Novel GCN2 Inhibitor for Acute Myeloid Leukemia (AML) Treatment Using Patient-Derived Models
Data Ecosystem
Not All Tumors Look Alike: Using Surfaceome Diversity to Enrich Responders
Data Ecosystem
Beyond Single Omic Biomarkers: How Proteogenomic ML Reveals Therapy Vulnerabilities
Feature selection in RNA-seq and proteomics with MADVAR in R
Choosing the Right CDX Models: Speed, Scientific Value, and Translational Relevance
Modeling next generation AR pathway inhibitors in prostate cancer
Data Ecosystem
Reducing Clinical Attrition: Why Stronger Data Needs to be the Starting Point for Oncology R&D
Radiopharmaceutical
Radiopharmaceutical Efficacy Studies in PDX Models: Why Tumor Diversity Matters
Radiopharmaceutical
Radiochemistry 101 for ADC Teams: A Practical Guide for Biodistribution Studies